AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Edgewise Therapeutics, Inc.

$38.90 +$15.15 (+63.79%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$38.91
Day Range
$38.02$39.44
Year Range
$16.70$48.51
Market Cap
4.19B
AVG Volume
1.35M
Trailing/Forward PE
-21.03/-
PEG ratio
-0.73
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Net Income (USD) · A
-200M-150M-100M-50M0202020212022202320242025
EWTX Net Income (USD) by year
PeriodNet Income (USD)
2025-167.79M
2024-133.81M
2023-100.16M
2022-67.64M
2021-42.81M
2020-17.12M
Operating Income (USD) · A
-200M-150M-100M-50M0202020212022202320242025
EWTX Operating Income (USD) by year
PeriodOperating Income (USD)
2025-191.41M
2024-158.83M
2023-114.36M
2022-71.66M
2021-43.22M
2020-17.19M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: EWTX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Edgewise Therapeutics, Inc.
EWTX
Stockpicker

Video analysis: EWTX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: EWTX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.